133 related articles for article (PubMed ID: 37962121)
1. Clinical Characteristics of Marginally Recurrent Melanoma After Primary Excision: A Multisite Retrospective Analysis of 140 Cases Referred for Mohs Surgery.
Soh JM; Brodland DG; Zitelli JA
Dermatol Surg; 2024 Feb; 50(2):131-136. PubMed ID: 37962121
[TBL] [Abstract][Full Text] [Related]
2. The invasive growth potential of residual melanoma and melanoma in situ.
DeBloom JR; Zitelli JA; Brodland DG
Dermatol Surg; 2010 Aug; 36(8):1251-7. PubMed ID: 20666813
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
Burnett ME; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
6. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
7. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
8. Local Recurrence Rates of Malignant Melanoma After Mohs Micrographic Surgery Are Lowest With 5- to 10-mm Initial Margins: A Systematic Review and Meta-Analysis.
Campbell EH; Crum OM; Chelf CJ; Demer AM; Brewer JD
Dermatol Surg; 2023 Feb; 49(2):119-123. PubMed ID: 36728060
[TBL] [Abstract][Full Text] [Related]
9. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
Foxton GC; Elliott TG; Litterick KA
Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
[TBL] [Abstract][Full Text] [Related]
10. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
12. Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review.
Heath M; Woody M; Leitenberger J; Latour E; Bar A
Dermatol Surg; 2020 Aug; 46(8):1004-1013. PubMed ID: 31714384
[TBL] [Abstract][Full Text] [Related]
13. The Controversy and Value of Mohs Micrographic Surgery for Melanoma and Melanoma in Situ on the Trunk and Extremities.
Zitelli JA; Stiegel E; Brodland DG
Dermatol Surg; 2023 Dec; 49(12):1061-1065. PubMed ID: 37962134
[TBL] [Abstract][Full Text] [Related]
14. Slow Mohs micrographic surgery for nail apparatus melanoma in situ.
Zhang S; Wang Y; Fang K; Jia Q; Zhang H; Qu T
Int J Dermatol; 2023 Sep; 62(9):1170-1175. PubMed ID: 37350436
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of invasive melanoma of the head and neck treated with Mohs micrographic surgery - A multicenter study.
Beal BT; Udkoff J; Aizman L; Etzkorn J; Zitelli JA; Miller CJ; Shin TM; Sobanko JF; Brodland DG
J Am Acad Dermatol; 2023 Sep; 89(3):544-550. PubMed ID: 36642331
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
18. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery: Rates of positive margins, local recurrence, and repeat surgeries.
Ran NA; Nugent ST; Veerabagu SA; Chu EY; Modi MB; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Walker JL; Stull CM; Miller CJ
J Am Acad Dermatol; 2022 Dec; 87(6):1376-1378. PubMed ID: 35963290
[No Abstract] [Full Text] [Related]
20. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
